Transparency is the key to the creation of confidence in relations with the general public and patients. That is why Mylan and BGP intend in future to disclose the pecuniary benefits provided between the pharmaceutical industry and stakeholders in the healthcare sector on this site.

Additional information can be found at:
www.en.scienceindustries.ch/involvement/pharma-code-and-pharma-cooperation-code/disclosure-obligation

Methodological Note
Report 2015
Report 2016